Drug intelligence / Profile preview

Melavenze

Development stage
Unknown
Lead developer
Makshi Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Melavenze is a pharmaceutical product marketed by Makshi Healthcare, typically used in the management of gastrointestinal disorders. While specific formulation details for this brand are limited in public clinical databases, it is categorized by the distributor under gastrointestinal (GI) treatments. In the Indian pharmaceutical market, brands with similar nomenclature often contain Mebeverine, an antispasmodic medication that works by relaxing the smooth muscles of the gastrointestinal tract without affecting normal gut motility. It is primarily indicated for the symptomatic treatment of irritable bowel syndrome (IBS) and related abdominal cramps. Makshi Healthcare operates as a pharmaceutical marketing and distribution company, providing branded generic versions of established therapeutic agents.

Brand names
Melavenze
Other names
Melavenze-Makshi

Beyond the preview

Go deeper on Melavenze.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melavenze.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call